Diabetes News and Research

Latest Diabetes News and Research

LA BioMed to participate in a national study of the effectiveness of testosterone

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) announced today that it will participate in a large national study of the effectiveness of testosterone as a treatment for anemia, cardiovascular disease, decreased vitality, impaired memory and sexual function, loss of muscle mass and other health conditions that affect older men.

13 Nov 2009

Positive results from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS

Lexicon Pharmaceuticals, Inc. announced today that the company's investigational new drug, LX1031, a tryptophan hydroxylase (TPH) inhibitor, demonstrated positive results in clinically important parameters for the treatment of non-constipating irritable bowel syndrome (IBS).

13 Nov 2009

Report on the epidemiology of PAD, TAO and CLI in India

A new analysis published by THE SAGE GROUP concludes that atherosclerotic peripheral arterial disease (PAD) afflicts over 20 million in India. Both PAD and CLI represent major and significantly underestimated problems for the Indian economy and healthcare system.

13 Nov 2009

BMC and Clear One Health Plans team up to offer first Focused Patient Care Model

Bend Memorial Clinic (BMC), the largest provider of quality, comprehensive and convenient physician healthcare in Central Oregon, has joined with Clear One Health Plans to offer the region’s first Focused Patient Care Model, similar to a Medical Home Model, beginning January 1, 2010. BMC’s team of more than 100 physicians and other providers care for approximately 3,800 Clear One Medicare Advantage members all of whom will qualify for the program.

13 Nov 2009

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

UT Southwestern Medical Center has been awarded more than $42 million to date for basic and patient-oriented research from the American Recovery and Reinvestment Act of 2009, the $787 billion stimulus package President Barack Obama signed into law in February.

13 Nov 2009

New Assure Pro blood glucose monitoring system from ARKRAY

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today announced the launch of a new and improved Assure Pro Blood Glucose Monitoring Test Strip.

12 Nov 2009

Will the health bill bend costs?

One cause for health reform anxiety is that no one is sure whether the legislation would achieve one of its most critical goals: lowering health care costs.

12 Nov 2009

American Medical Alert announces operating results for the third quarter of 2009

American Medical Alert Corp. a provider of healthcare communication services and advanced telehealth monitoring technologies, today announced operating results for the quarter and nine months ended September 30, 2009.

12 Nov 2009

Gene within the pancreas affecting insulin secretion discovered

How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. Their work opens the way for a new understanding of possible paths to battle diabetes and diabetes-related health problems, which are on the rise all over the world.

12 Nov 2009

Gene variants which influence insulin metabolism can also affect birth weight

Low birth weight increases the risk of developing type 2 diabetes later in life. Until recently scientists had attributed this to maternal malnutrition during pregnancy. However, now it seems that genetic background may also play a major role. A research team of Technische Universität München and Helmholtz Zentrum München has now demonstrated, that gene variants which influence insulin metabolism can also affect birth weight.

12 Nov 2009

On-line journal Diabetic Hypoglycemia calls for greater understanding and taking control of diabetes

The on-line journal Diabetic Hypoglycemia (http://www.hypodiab.com/) supports the message of World Diabetes Day 2009 (http://www.worlddiabetesday.org) in their call for greater understanding and taking control of diabetes.

12 Nov 2009

Stapled Peptides directly inhibit the Notch transcription factor complex

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, “Direct Inhibition of the Notch Transcription Factor Complex.”

12 Nov 2009

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

An important, ground-breaking initiative is unfolding in the global critical care community in response to the H1N1 pandemic.

12 Nov 2009

Impact of health insurance reform on Americans with diabetes: HHS report

As the nation marks American Diabetes Month, HHS Secretary Kathleen Sebelius released a new report today, Preventing and Treating Diabetes: Health Insurance Reform and Diabetes in America. The report comes one day after Sebelius toured the East Manatee Family Healthcare Center in Bradenton, Fla. At the center, Sebelius met with patients and Floridians who care for people with diabetes.

12 Nov 2009

MinuteClinic praises practitioners for providing affordable medical treatment and quality patient-centered care

In celebration of National Nurse Practitioner Week (Nov. 8-14), MinuteClinic, the pioneer and largest provider of retail health care centers in the United States, salutes practitioners across the country who deliver patient-centered care and help to increase access to high-quality, affordable medical treatment.

12 Nov 2009

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

Geron Corporation today announced the publication of data showing that oligodendrocyte progenitor cells (OPCs) derived from human embryonic stem cells (hESCs), when transplanted into a rodent model of cervical spinal cord injury, reduced tissue damage within the lesion and improved recovery of locomotor function.

12 Nov 2009

Stapled Peptides can inhibit key intracellular biological targets, says new research

Aileron Therapeutics, a biopharmaceutical company leading the development of a new class of drugs called Stapled Peptides, announced today that its collaborators, James E. Bradner, MD of the Dana-Farber Cancer Institute and the Broad Institute of Harvard and MIT, and Gregory L. Verdine, PhD, Professor of Chemistry at Harvard University, published research in Nature entitled, "Direct Inhibition of the Notch Transcription Factor Complex." Results presented in the paper showed that Stapled Peptides can potently and directly inhibit the transcription factor Notch, an oncogene implicated in cancer cell proliferation and survival.

12 Nov 2009

54% of Americans are inconsistent in taking prescriptions, reveals survey

A new survey finds that 54 percent of Americans say they do not consistently take prescriptions as instructed even though 87 percent believe prescription medicines are important to their health – pointing to a growing public health problem.

12 Nov 2009

Nuvo Research announces new licensing agreement for Oxoferin

Nuvo Research Inc., a Canadian drug development company focused on the research and development of drug products that are delivered to and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced a new licensing agreement for Oxoferin(TM), its topical wound healing agent, and additional details of the funding assistance to be provided by the Development Bank of Saxony for the development of WF10.

12 Nov 2009

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

Emergency Management & Safety Solutions (EMS Solutions), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help companies better prepare for and prevent transmission of this year's H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and approximately 6,500 people have died -- including over 1,500 in North America, according to the European Center for Disease Prevention and Control.

12 Nov 2009

Diabetes News and Research

Latest Diabetes News and Research

LA BioMed to participate in a national study of the effectiveness of testosterone

Positive results from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS

Report on the epidemiology of PAD, TAO and CLI in India

BMC and Clear One Health Plans team up to offer first Focused Patient Care Model

UT Southwestern Medical Center awarded $42M for basic and patient-oriented research

New Assure Pro blood glucose monitoring system from ARKRAY

Will the health bill bend costs?

American Medical Alert announces operating results for the third quarter of 2009

Gene within the pancreas affecting insulin secretion discovered

Gene variants which influence insulin metabolism can also affect birth weight

On-line journal Diabetic Hypoglycemia calls for greater understanding and taking control of diabetes

Stapled Peptides directly inhibit the Notch transcription factor complex

Canadian researchers organize clinical trials to find new treatments for H1N1 infection

Impact of health insurance reform on Americans with diabetes: HHS report

MinuteClinic praises practitioners for providing affordable medical treatment and quality patient-centered care

Transplantation of hESC-derived OPCs spare spinal cord tissue in the cervical lesion site: Study

Stapled Peptides can inhibit key intracellular biological targets, says new research

54% of Americans are inconsistent in taking prescriptions, reveals survey

Nuvo Research announces new licensing agreement for Oxoferin

EMS Solutions provides free resources to help companies tackle this year's H1N1 flu pandemic

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Diabetes News and Research

Latest Diabetes News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in